focus -WSS

focus

author：comprehensive 2025-09-29 14:00:07 - browse：7951

3D dollar signs come out of a prescription drug bottle — coverage from STAT — Adobe

WASHINGTON — Venture capitalists are still pouring money into drug research in spite of Medicare’s new power to negotiate drug prices, according to Congress’ nonpartisan budget experts.

The Inflation Reduction Act includes two measures that directly lower drug prices. Medicare price negotiation is the most controversial of the two. The law gives drugs 9 years on the market before negotiated prices take effect; biologics get 13 years. Drugs are selected for negotiation among the 50 top-selling drugs without generic or biosimilar competition. Medicare will negotiate prices for 10 drugs to start. Up to 60 drugs will be subject to negotiation over the next four years, and up to 20 more drugs every year afterward.

The law also requires drug companies to pay back Medicare when they raise prices on drugs faster than inflation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： Scrutiny of post

Wikipedia

WSS

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

UnitedHealth argues against case alleging wrongful AI care denials

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Investigation reveals sickle cell patients pressured into sterilizations

Weight loss drug costs may need more research, senator suggests

Wegovy, Zepbound and weight loss drugs that preserve muscle

knowledge

focus

leisure time

Medical records are filled with copy

Weight loss drug costs may need more research, senator suggests

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

H5N1 virus can be tracked in retail milk, scientists say

United colonoscopy coverage change 'may cost lives,' doctors say

U.K. considers world's first use of meningitis vaccine to address gonorrhea

State Dept. review finds Biden bears some blame for Afghanistan failures

Weight loss drug costs may need more research, senator suggests

Dobbs anniversary: the lost opportunity of abortion as health care

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

hotspot

World's first CRISPR

Wegovy, Zepbound and weight loss drugs that preserve muscle

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

For longer

Scrutiny of post

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

hotspot

Wikipedia

focus

focus